Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation

Exclusion Criteria

• •Male
• •Patients with clinical evidence of gross disease
• •Patients who are pregnant or breastfeeding
• •Prior radiation therapy to the ipsilateral chest wall or thorax
• •Patients requiring a chest wall boost
• •Concurrent chemotherapy (biologic agents are allowed)
• •Psychiatric illness that would prevent the patient from giving informed consent
• •Inability or unwillingness to comply with skin care instructions and follow-up
• •Allergy to either Eucerin or MF
• •Residual grade \>1 skin toxicity, cellulitis, or incompletely healed wound(s) at intended site of study drug application at the time of the start of RT
• •Medical condition such as uncontrolled infection (including HIV), uncontrolled diabetes mellitus, or connective tissue diseases (lupus, systemic sclerosis, or other collagen vascular diseases)
• •Treatment with palliative or pre-operative radiation